Fortress Biotech, Inc. - 02 Jan 2026 SCHEDULE 13D/A Report for Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value (ATXI)

Filing Manager: Fortress Biotech, Inc.
Reporting Manager: Fortress Biotech, Inc.
Security: Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value
Symbol: ATXI
Shares outstanding: 3,283,246 shares
Disclosed Ownership: 439,955 shares
Ownership: 13%
Form type: SCHEDULE 13D/A
Filing time: 06 Jan 2026, 16:11:21 UTC
Date of event: 02 Jan 2026
Previous filing: 02 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Fortress Biotech, Inc.	13%	439,955	439,955	0	/s/ Lindsay A. Rosenwald	Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer	0001429260